Zoetis (ZTS) share buybacks: $3.2B
Zoetis spent $3.2B buying back its own shares in the year ended Dec 31, 2025, up 74.1% from $1.9B a year earlier.
From Zoetis's filings with the SEC · Read the filing · ZTS stock page
Zoetis share buybacks by year
#64 of 1,890 US companies by share buybacks · See the full ranking
| Year ended | Share buybacks | Change |
|---|---|---|
| Dec 31, 2025 | $3.2B | +74% |
| Dec 31, 2024 | $1.9B | +70% |
| Dec 31, 2023 | $1.1B | -31% |
| Dec 31, 2022 | $1.6B | +115% |
| Dec 31, 2021 | $743M | – |
Share buybacks of similar companies
Companies in the same industry as Zoetis, by SEC industry code, with the closest share buybacks. Each name opens the same page for that company.
| Company | Share buybacks, latest year | Year ended |
|---|---|---|
| Johnson & Johnson | $6B | Dec 28, 2025 |
| Merck | $5.1B | Dec 31, 2025 |
| Eli Lilly | $4.1B | Dec 31, 2025 |
| Regeneron Pharmaceuticals | $3.4B | Dec 31, 2025 |
| Zoetis | $3.2B | Dec 31, 2025 |
| Vertex Pharmaceuticals Inc / Ma | $2B | Dec 31, 2025 |
| Royalty Pharma | $1.2B | Dec 31, 2025 |
Questions and answers
What is Zoetis's share buybacks?
Zoetis spent $3.2B buying back its own shares in the year ended Dec 31, 2025, up 74.1% from $1.9B a year earlier.
Numbers as reported in Zoetis's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology